R. Fujimoto

Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH(1–34) administration

Noriaki Yamamoto, Hideaki E. Takahashi, Tatsuhiko Tanizawa et al. · Bone and Mineral · 1993 · 35 citations

Bone Disease, Physical Activity, Bone Health +13

A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration

S. Yokota, S. Sonohara, Mutsumi Yoshida et al. · International Journal of Pharmaceutics · 2001 · 27 citations

Tissue Engineering, Regeneration, Regenerative Medicine +11

Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on rat bone: Inhibition of bone formation at the endosteal surface of vertebra and tibia

Shigeru Soshi, Hideaki Takahashi, Tatsuhiko Tanizawa et al. · Calcified Tissue International · 1996 · 22 citations

Regenerative Medicine, Inflammation, Rat Bone +9

Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier

S. Yokota, Takafumi Uchida, Satoshi Kokubo et al. · International Journal of Pharmaceutics · 2003 · 18 citations

Regenerative Medicine, Developmental Biology, Bone Morphogenic Protein +7

[Clinical studies using measurement of N-telopeptides of type 1 collagen (NTx) in patients with bone metastasis--comparison with bone scintigraphy and other metabolic bone markers].

Ikuo Yamamoto, Rikushi Morita, J Konishi et al. · PubMed · 1995 · 10 citations

Orthopaedic Surgery, Osteoporosis, Bone Disease +16